市場調査レポート

商品コード

1403461

マイクロバイオームシーケンスサービス市場の2030年までの予測：タイプ、サービス、技術、用途、エンドユーザー、地域別の世界分析

Microbiome Sequencing Services Market Forecasts to 2030 - Global Analysis By Type, Service, Technology, Application, End User and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 597,849円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 756,315円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 914,781円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,080,450円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、マイクロバイオームシーケンスサービスの世界市場は2023年に15億4,000万米ドルを占め、予測期間中のCAGRは12.9％で成長し、2030年には36億1,000万米ドルに達する見込みです。

マイクロバイオームシーケンスサービスは、サンプル中の微生物のDNAを解析し、ヒトの腸のような特定の環境に生息する微生物の多様なコミュニティに関する詳細を明らかにします。これは、個別化医療、疾病診断、微生物叢と様々な生態系との間の複雑な相互作用の理解を進める上で極めて重要です。これらのサービスは微生物種を同定・定量化し、研究者や臨床医がマイクロバイオームの構成と機能を理解するのに役立ちます。

キャンサー・オーストラリアが2022年に更新したデータによると、2022年にオーストラリアで新たにがんと診断される症例は162,163人で、そのうち男性が88,982人、女性が73,181人と推定されています。

バイオ医薬品調査の拡大

バイオ医薬品企業は、マイクロバイオームがヒトの健康や疾病に及ぼす極めて重要な役割を認識しつつあり、標的療法や精密医療アプローチの開発に道を開いています。バイオ医薬品企業はマイクロバイオームシーケンスを活用して前臨床試験や臨床試験を実施し、治療介入が微生物の生態系に与える影響を理解することを目指しています。さらに、特に腸内マイクロバイオームの探索は、薬物の代謝、有効性、安全性を調節する可能性があるとして注目を集めており、この市場規模を押し上げています。

高コスト

小規模な研究機関、学術研究所、新興企業は、高額なコストのためにマイクロバイオームシーケンスサービスを徹底的に実施できないという独自の財政課題に直面しています。研究者や組織にとって経済的な障害は、サンプル収集、DNA抽出、ライブラリー調製、データ解析を含むこれらの高コストによって悪化しています。さらに、高度なシーケンス技術とバイオインフォマティクスの知識を必要とするマイクロバイオーム解析の複雑さが、これらのサービスの全体的な高コストに拍車をかけ、この市場規模の妨げとなっています。

シーケンス技術の革新

技術の進歩により、研究者は膨大な量のデータを生成できるようになり、多様な生態系内の微生物群集のより包括的な理解が容易になった。次世代シーケンサー（NGS）プラットフォーム、イルミナ、サーモフィッシャーなどの技術は、マイクロバイオームシーケンスの深さと幅を大幅に向上させました。さらに、シーケンス精度の向上、リード長の延長、スループットの向上は、より広範な微生物種の同定と特性解析に貢献し、それによってこの市場の拡大を後押ししています。

標準化に伴うリスク

異なるプラットフォームやサービスプロバイダー間でプロトコル、手法、データ解析手順が統一されていないため、結果の比較や解釈に課題が生じます。このようなばらつきは、微生物群集プロファイリングにおける矛盾につながる可能性があります。さらに、サンプル採取、DNA抽出、シーケンスライブラリー調製において標準化された手法が存在しないため、マイクロバイオームデータに偏りや誤りが生じる可能性があります。これは学術研究に影響を与えるだけでなく、マイクロバイオームシーケンスの臨床応用や規制の枠組みへの移行にも影響し、市場の成長を阻害します。

COVID-19の影響

COVID-19の流行はマイクロバイオームシーケンスサービス市場に様々な形で悪影響を及ぼしています。サプライチェーンの混乱、ロジスティクスの課題、ラボ活動の制限により、マイクロバイオームシーケンスサービスのシームレスな運用が阻害されました。多くの研究機関やバイオテクノロジー企業が財政的制約に直面し、マイクロバイオーム研究やシーケンスサービスへの投資がさらに制限されました。さらに、臨床試験や学術研究活動により、学術的および産業的な環境におけるマイクロバイオームシーケンスサービスの需要が減少し、この市場の成長を阻害しました。

予測期間中、全ゲノムシーケンスセグメントが最大となる見込み

全ゲノムシーケンス分野は、広範な遺伝情報を取得する能力により、微生物群集内の希少種や変異の検出が可能になるため、推定・予測期間中に最大のシェアを占めると予測されます。さらに、この技術では生物のDNA全体の配列を決定するため、遺伝子構成、機能要素、潜在的な病原性因子を詳細に理解することができます。この技術は、発見を促進し、治療的介入を導くのに役立っており、それによってこのセグメントの成長を牽引しています。

ライゲーションによるシーケンス（SBL）セグメントは予測期間中最も高いCAGRが見込まれる

ライゲーションによるシークエンシング（SBL）セグメントは、予測期間中にCAGRが最も高くなると予測されています。SBLでは、DNA断片が特定のアダプターを用いてライゲーションされ、連結構造を形成します。これにより、高い精度、長いリード長、困難なゲノム領域からの情報取得能力などの利点が得られます。さらに、研究者やサービスプロバイダーは微生物ゲノムの包括的な洞察を得ることができ、コミュニティダイナミクス、機能的可能性、宿主とマイクロバイオームの相互作用の理解に役立ちます。

最大のシェアを占める地域

精密医療と個別化ヘルスケアの重要性の高まりと相まって、マイクロバイオームが健康と疾病に与える影響に対する認識が高まっているため、アジア太平洋地域が推定期間中に最大の市場シェアを占めました。中国、日本、韓国、インドのような国々は、研究機関、バイオテクノロジー企業、シーケンスサービスプロバイダ間の連携を促進しています。さらに、研究能力とインフラが強化され続ける中、ハイスループットシーケンス技術とバイオインフォマティクス機能の進歩がこの地域の成長をさらに後押ししています。

CAGRが最も高い地域：

予測期間中、欧州のCAGRが最も高くなると予想されます。欧州全域の多様な人口がマイクロバイオーム研究に豊かな環境を提供し、研究者は微生物組成のバリエーションとそれらが地域の健康パターンに与える影響を調査することができます。また、Illumina, Inc.、Macrogen, Inc.、Genewiz、Eurofins Scientificなどの主要企業は、個別化医療、農業慣行、微生物生態系の理解の進歩に大きく貢献しており、この地域の拡大を牽引しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第12章企業プロファイル

DNA Genotek Inc.
Thermo Fisher Scientific Inc.
Illumina, Inc.
Metabiomics
CosmosID
Zymo Research Corporation
PerkinElmer, Inc.
BGI Genomics Co., Ltd.
Rancho Biosciences
Baseclear BV
Diversigen, Inc.
Merieux Nutrisciences Corporations
Clinical Microbiomics AS
Bio-Rad Laboratories, Inc.
Genewiz Inc.

図表

List of Tables

Table 1 Global Microbiome Sequencing Services Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 4 Global Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 5 Global Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 6 Global Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 7 Global Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 8 Global Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 9 Global Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 10 Global Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 11 Global Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 12 Global Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 13 Global Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 14 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 15 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 16 Global Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 17 Global Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 18 Global Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 19 Global Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 20 Global Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 21 Global Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 22 Global Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 23 Global Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 24 Global Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 25 Global Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 26 Global Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Table 27 North America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
Table 28 North America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 29 North America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 30 North America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 31 North America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 32 North America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 33 North America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 34 North America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 35 North America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 36 North America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 37 North America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 38 North America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 39 North America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 40 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 41 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 42 North America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 43 North America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 44 North America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 45 North America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 46 North America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 47 North America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 48 North America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 49 North America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 50 North America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 51 North America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 52 North America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Table 53 Europe Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
Table 54 Europe Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 55 Europe Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 56 Europe Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 57 Europe Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 58 Europe Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 59 Europe Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 60 Europe Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 61 Europe Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 62 Europe Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 63 Europe Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 64 Europe Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 65 Europe Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 66 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 67 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 68 Europe Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 69 Europe Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 70 Europe Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 71 Europe Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 72 Europe Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 73 Europe Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 74 Europe Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 75 Europe Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 76 Europe Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 77 Europe Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 78 Europe Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Table 79 Asia Pacific Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
Table 80 Asia Pacific Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 81 Asia Pacific Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 82 Asia Pacific Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 83 Asia Pacific Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 84 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 85 Asia Pacific Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 86 Asia Pacific Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 87 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 88 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 89 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 90 Asia Pacific Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 91 Asia Pacific Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 92 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 93 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 94 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 95 Asia Pacific Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 96 Asia Pacific Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 97 Asia Pacific Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 98 Asia Pacific Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 99 Asia Pacific Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 100 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 101 Asia Pacific Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 102 Asia Pacific Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 103 Asia Pacific Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 104 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Table 105 South America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
Table 106 South America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 107 South America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 108 South America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 109 South America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 110 South America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 111 South America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 112 South America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 113 South America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 114 South America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 115 South America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 116 South America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 117 South America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 118 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 119 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 120 South America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 121 South America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 122 South America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 123 South America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 124 South America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 125 South America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 126 South America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 127 South America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 128 South America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 129 South America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 130 South America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Table 131 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
Table 132 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
Table 133 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
Table 134 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
Table 135 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
Table 136 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
Table 137 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
Table 138 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
Table 139 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
Table 140 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
Table 141 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
Table 142 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
Table 143 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
Table 144 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
Table 145 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
Table 146 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 147 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
Table 148 Middle East & Africa Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
Table 149 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 150 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
Table 151 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 152 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
Table 153 Middle East & Africa Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
Table 154 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 155 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 156 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24686

According to Stratistics MRC, the Global Microbiome Sequencing Services Market is accounted for $1.54 billion in 2023 and is expected to reach $3.61 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Microbiome sequencing services analyze the DNA of microorganisms in a sample to reveal details about the diverse community of microbes living in a particular environment, like the human gut. It is crucial for personalized medicine, disease diagnostics, and advancing our understanding of the intricate interplay between microbiota and various ecosystems. These services identify and quantify microbial species, helping researchers and clinicians understand the microbiome's composition and function.

According to the data updated by Cancer Australia in 2022, it was estimated that 162,163 new cases of cancer would be diagnosed in Australia in 2022, out of which 88,982 would be males and 73,181 females.

Market Dynamics:

Driver:

Expanding biopharmaceutical research

Biopharmaceutical companies are increasingly recognizing the pivotal role of the microbiome in influencing human health and disease, paving the way for the development of targeted therapies and precision medicine approaches. Biopharmaceutical companies leverage microbiome sequencing to conduct preclinical and clinical trials, aiming to understand the impact of therapeutic interventions on microbial ecosystems. Furthermore, the exploration of the gut microbiome, in particular, has garnered attention for its potential in modulating drug metabolism, efficacy, and safety, which is boosting this market size.

Restraint:

High cost

Smaller research institutions, academic laboratories, and startups face unique financial challenges that prevent their capacity to conduct thorough microbiome sequencing services due to high costs. Financial obstacles for researchers and organizations are made worse by these high costs, which include sample collection, DNA extraction, library preparation, and data analysis. Additionally, the complexity of microbiome analysis, which necessitates sophisticated sequencing technologies and bioinformatics knowledge, adds to the overall high cost of these services, which is hindering this market size.

Opportunity:

Innovations in sequencing technologies

The technological strides enable researchers to generate vast amounts of data, facilitating a more comprehensive understanding of microbial communities within diverse ecosystems. Technologies such as next-generation sequencing (NGS) platforms, Illumina's, and Thermo Fisher's offerings have significantly enhanced the depth and breadth of microbiome sequencing. Furthermore, improved sequencing accuracy, longer read lengths, and increased throughput contribute to the identification and characterization of a wider range of microbial species, thereby propelling this market expansion.

Threat:

Risks associated with standardization

The lack of uniformity in protocols, methodologies, and data analysis procedures across different platforms and service providers introduces challenges in comparing and interpreting results. This variability can lead to inconsistencies in microbial community profiling. Furthermore, the absence of standardized practices in sample collection, DNA extraction, and sequencing library preparation can contribute to biases and errors in microbiome data. This not only affects academic research but also impacts the translation of microbiome sequencing into clinical applications and regulatory frameworks, hindering the market's growth.

COVID-19 Impact

The COVID-19 pandemic has negatively impacted the microbiome sequencing services market in various ways. Disruptions in supply chains, logistical challenges, and restrictions on laboratory activities have impeded the seamless operation of microbiome sequencing services. Many research institutions and biotechnology companies faced financial constraints, further limiting investments in microbiome studies and sequencing services. Additionally, clinical trials and academic research activities decreased demand for microbiome sequencing services in both academic and industrial settings, impeding this market's growth.

The whole-genome sequencing segment is expected to be the largest during the forecast period

The whole-genome sequencing segment is estimated to hold the largest share during the forecast period, due to its ability to capture a broad spectrum of genetic information, enabling the detection of rare species and variations within microbial communities. Additionally, this technique involves sequencing the entire DNA of an organism, providing a detailed understanding of its genetic makeup, functional elements, and potential virulence factors. It is instrumental in fueling discoveries and guiding therapeutic interventions, thereby driving this segment's growth.

The sequencing by ligation (SBL) segment is expected to have the highest CAGR during the forecast period

The sequencing by ligation (SBL) segment is anticipated to have highest CAGR during the forecast period. In SBL, DNA fragments are ligated together using specific adapters, forming a concatemeric structure. This offers advantages such as high accuracy, long read lengths, and the ability to capture information from challenging genomic regions. In addition, researchers and service providers obtain comprehensive insights into microbial genomes, aiding in the understanding of community dynamics, functional potential, and host-microbiome interactions, which are boosting this market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness of the microbiome's impact on health and disease, coupled with a rising emphasis on precision medicine and personalized healthcare. Countries like China, Japan, South Korea, and India foster collaborations between research institutions, biotechnology companies, and sequencing service providers. In addition, as research capabilities and infrastructure continue to strengthen the advancements in high-throughput sequencing technologies and bioinformatics capabilities further propel the region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The diverse population across Europe provides a rich landscape for microbiome studies, enabling researchers to explore variations in microbial compositions and their impact on regional health patterns. Key players such as Illumina, Inc., Macrogen, Inc., Genewiz, and Eurofins Scientific also contribute significantly to advancements in personalized medicine, agricultural practices, and our understanding of microbial ecosystems, thus driving this region's expansion.

Key players in the market:

Some of the key players in the Microbiome Sequencing Services Market include DNA Genotek Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Metabiomics, CosmosID, Zymo Research, Corporation, PerkinElmer, Inc., BGI Genomics Co., Ltd., Rancho Biosciences, Baseclear BV, Diversigen, Inc., Merieux Nutrisciences Corporations, Clinical Microbiomics AS, Bio-Rad Laboratories, Inc. and Genewiz Inc.

Key Developments:

In November 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies announced the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs).

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In July 2023, Bio-Rad Laboratories, Inc. announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

Types Covered:

Shotgun Sequencing
Whole-genome Sequencing
Amplicon Sequencing
Other Types

Services Covered:

Data Analysis
Sample Preparation
Sequencing Library Preparation
Other Services

Technologies Covered:

Targeted Gene Sequencing
Sequencing by Ligation (SBL)
Sequencing by Synthesis (SBS)
Other Technologies

Applications Covered:

CNS Diseases
Oncology
Gastrointestinal Diseases
Infectious Diseases
Other Applications

End Users Covered:

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Microbiome Sequencing Services Market, By Type

5.1 Introduction
5.2 Shotgun Sequencing
5.3 Whole-genome Sequencing
5.4 Amplicon Sequencing
5.5 Other Types

6 Global Microbiome Sequencing Services Market, By Service

6.1 Introduction
6.2 Data Analysis
6.3 Sample Preparation
6.4 Sequencing Library Preparation
6.5 Other Services

7 Global Microbiome Sequencing Services Market, By Technology

7.1 Introduction
7.2 Targeted Gene Sequencing
7.3 Sequencing by Ligation (SBL)
7.4 Sequencing by Synthesis (SBS)
7.5 Other Technologies

8 Global Microbiome Sequencing Services Market, By Application

8.1 Introduction
8.2 CNS Diseases
8.3 Oncology
8.4 Gastrointestinal Diseases
8.5 Infectious Diseases
8.6 Other Applications

9 Global Microbiome Sequencing Services Market, By End User

9.1 Introduction
9.2 Academic and Research Institutes
9.3 Pharmaceutical and Biotechnology Companies
9.4 Other End Users

10 Global Microbiome Sequencing Services Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 DNA Genotek Inc.
12.2 Thermo Fisher Scientific Inc.
12.3 Illumina, Inc.
12.4 Metabiomics
12.5 CosmosID
12.6 Zymo Research Corporation
12.7 PerkinElmer, Inc.
12.8 BGI Genomics Co., Ltd.
12.9 Rancho Biosciences
12.10 Baseclear BV
12.11 Diversigen, Inc.
12.12 Merieux Nutrisciences Corporations
12.13 Clinical Microbiomics AS
12.14 Bio-Rad Laboratories, Inc.
12.15 Genewiz Inc.

マイクロバイオームシーケンスサービス市場の2030年までの予測：タイプ、サービス、技術、用途、エンドユーザー、地域別の世界分析

Microbiome Sequencing Services Market Forecasts to 2030 - Global Analysis By Type, Service, Technology, Application, End User and By Geography

バイオ医薬品調査の拡大

高コスト

シーケンス技術の革新

標準化に伴うリスク

COVID-19の影響

予測期間中、全ゲノムシーケンスセグメントが最大となる見込み

ライゲーションによるシーケンス（SBL）セグメントは予測期間中最も高いCAGRが見込まれる

最大のシェアを占める地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のマイクロバイオームシーケンスサービス市場：タイプ別

第6章 世界のマイクロバイオームシーケンスサービス市場：サービス別

第7章 世界のマイクロバイオームシーケンスサービス市場：技術別

第8章 世界のマイクロバイオームシーケンスサービス市場：用途別

第9章 世界のマイクロバイオームシーケンスサービス市場：エンドユーザー別

第10章 世界のマイクロバイオームシーケンスサービス市場：地域別

第11章 主な発展

第12章 企業プロファイル